DeepView System

Dallas’ Spectral AI Is Developing a Battlefield Burn Assessment Tool

by | Jul 31, 2024
The company noted that burn wounds account for a significant portion of combat-related injuries. Its DeepView SnapShot M device is designed to be an integral part of the battlefield triage process by providing a quick and accurate wound assessment, so that those with more severe burn injuries can be prioritized for evacuation.
MORE
Dallas’ Spectral AI Appoints Chief Commercialization Officer
by | May 31, 2024

Dallas-based artificial intelligence company Spectral AI Inc. has appointed Jeremiah A. Sparks as chief commercialization officer. Spectral AI focuses on medical diagnostics for faster and more accurate treatment decisions in wound care....

MORE
Spectral AI Names EVP to Spearhead UK Subsidiary, Global Expansion of Imaging Tech
by | Oct 27, 2023
Spectral AI has recently secured its largest contract to date from the U.S. government, an award exceeding $149 million, boosting its total U.S. government awards accrued since 2019 to more than $246 million, as it aims to revolutionize wound care. The company's DeepView SnapShot Wound Imaging System, has received UK Conformity Assessed (UKCA) marking for use in the United Kingdom and has been classified as a Class 1 medical device by U.S. FDA.
MORE
Spectral AI Appoints ‘High-Impact’ Healthcare Exec to its Board of Directors
by | Oct 6, 2023
In September, the firm began trading on Nasdaq and secured a BARDA Project BioShield contract worth up to $149 million.
MORE